We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
Cap. Flow
+$2.78B
Cap. Flow %
12.74%
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699

Sector Composition

Rank Sector Weight
1 Healthcare 20.03%
2 Consumer Discretionary 13.15%
3 Technology 10.68%
4 Financials 9.81%
5 Communication Services 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NNN icon
1576
NNN REIT
NNN
$9.37B
$1.17M 0.01%
26,477
-283
-1% -$11.9K
LE icon
1577
Lands' End
LE
$389M
$1.17M 0.01%
46,983
+13,791
+42% +$404K
TCON
1578
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$1.16M 0.01%
+7,068
New +$1.36M
BWEN icon
1579
Broadwind
BWEN
$92.9M
$1.16M 0.01%
+175,551
New +$1.41M
BRK.A icon
1580
Berkshire Hathaway Class A
BRK.A
$1.1T
$1.16M 0.01%
+3
New +$1.1M
LUV icon
1581
PUT
Southwest Airlines
LUV
$22.7B
$1.15M 0.01%
+18,800
New +$1M
GLNG icon
1582
Golar LNG
GLNG
$4.95B
$1.15M 0.01%
111,949
-109,128
-49% -$1.23M
SIG icon
1583
Signet Jewelers
SIG
$3.81B
$1.15M 0.01%
19,740
-58,252
-75% -$2.74M
STRA icon
1584
Strategic Education
STRA
$1.84B
$1.15M 0.01%
12,460
-52,750
-81% -$4.73M
HCAQ
1585
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
$1.14M 0.01%
+113,884
New +$1.17M
NAV
1586
DELISTED
Navistar International
NAV
$1.13M 0.01%
25,765
-6,481
-20% -$286K
GE icon
1587
GE Aerospace
GE
$377B
$1.13M 0.01%
+17,308
New +$1.05M
CONN
1588
DELISTED
Conn's Inc.
CONN
$1.13M 0.01%
58,136
-11,732
-17% -$173K
STIM icon
1589
Neuronetics
STIM
$130M
$1.13M 0.01%
+90,912
New +$1.39M
ROL icon
1590
Rollins
ROL
$18.8B
$1.12M 0.01%
32,665
+6,455
+25% +$231K
EWI icon
1591
iShares MSCI Italy ETF
EWI
$993M
$1.12M 0.01%
+35,497
New +$1.08M
SIEB icon
1592
Siebert Financial
SIEB
$65.5M
$1.12M 0.01%
+275,965
New +$1.33M
GIB icon
1593
CGI
GIB
$15B
$1.12M 0.01%
+13,400
New +$1.06M
TBCH
1594
Turtle Beach Corp
TBCH
$258M
$1.12M 0.01%
41,881
-75,960
-64% -$2.08M
PAHC icon
1595
Phibro Animal Health
PAHC
$1.48B
$1.11M 0.01%
45,692
-30,286
-40% -$684K
XLE icon
1596
PUT
State Street Energy Select Sector SPDR ETF
XLE
$38.3B
$1.11M 0.01%
+45,400
New +$1.05M
FLXN
1597
DELISTED
Flexion Therapeutics, Inc.
FLXN
$1.11M 0.01%
+124,512
New +$1.43M
FTS icon
1598
Fortis
FTS
$29.7B
$1.11M 0.01%
25,600
-25,614
-50% -$1.05M
ALACW
1599
CALL
DELISTED
Alberton Acquisition Corp Warrant
ALACW
$1.11M 0.01%
+101,334
New +$100K
PSFE icon
1600
Paysafe
PSFE
$463M
$1.11M 0.01%
+6,830
New +$1.11M

Similar funds

Marshall Wace's Q1 2021 Portfolio in Review

As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.

  • Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
  • Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
  • Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
  • Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
  • Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
  • Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.

Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.